Issue No. 40. We looked back at a year of coverage to ask what's genuinely different in this market now versus when we started — and what hasn't moved at all.
Forty issues in, it's worth stepping back from any single compound or company to ask a bigger question: what has actually changed in this industry over the stretch of time we've been covering it, and what's exactly the same as it was in our earliest reporting.
“The biggest thing that hasn't changed in a year: a buyer still has to do most of the verification work themselves.”
— from this newsletter's own year-in-review discussionIssue No. 40. We looked back at a year of coverage to ask what's genuinely different in this market now versus when we started — and what hasn't moved at all.
It's marketed as an improved, more stable version of BPC-157. The modification is real chemistry — the comparative human evidence for the claimed improvement isn't there yet.
It's an approved diagnostic and therapeutic hormone with a specific, narrow clinical use. The way it's actually used in this market looks nothing like that.
Sellers lose ad accounts and social pages on a recurring cycle. The pattern behind it says something about how major platforms actually classify this entire category.
The original mouse study produced some of the more striking before-and-after images in aging research. Human data has not followed at anything like the same pace.
Both sound like a seller admitting a problem. They mean very different things about who found the issue and why.
Every issue, we run a few dispatches from readers — their own research, their own tracking, their own questions. These are personal accounts, not claims, and not medical advice. Read more letters →
I started keeping a proper log after reading your COA explainer — lot numbers, dates, which lab tested what. It sounds obsessive until the one week something doesn’t add up, and suddenly you’re glad you have it. Made me a much more careful buyer.
The cold chain piece finally explained something that had been bugging me for months — why two orders from the same supplier looked completely different on arrival. It was never the compound. It was August in a cardboard box.
I’ve been in this community three years and this is the first outlet that talks to us like we can handle nuance. Not everything needs to be "miracle" or "scam." Sometimes it’s just: here’s what the data says, here’s what it doesn’t.